Neuro Immunoassay Market Report 2026
Download Free Sample Buy Now
Neuro Immunoassay Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Neuro Immunoassay Market Report 2026

Global Outlook – By Product Type (Reagents And Kits, Analyzers), By Technology (Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests, Enzyme-Linked Immunospot Assay (ELISPOT)), By Analyte Or Biomarker Type (Amyloid-Beta (Aß), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L–, Brain-Derived Neurotrophic Factor (BDNF)), By Application (Alzheimer’s Disease, Parkinson’s Disease), By End-User (Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neuro Immunoassay Market Overview

• Neuro Immunoassay market size has reached to $2.88 billion in 2025

• Expected to grow to $4.28 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%

• Growth Driver: Growing Burden Of Neurological Conditions Driving Market Demand Due To Rising Prevalence And Early Diagnosis Needs

• Market Trend: Developing Blood-Based Neurological Biomarker Assays To Enhance Neuro Immunoassay Diagnostics And Disease Monitoring

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neuro Immunoassay Market?

Neuro immunoassay refers to the use of immunoassay techniques specifically designed to detect and quantify biomarkers and analytes related to neurological disorders and brain function. Its primary purpose is to enable accurate diagnosis, monitoring, and research of neurological conditions through sensitive and specific biochemical assays. It also supports drug development, personalized medicine, and the understanding of neurodegenerative and neuroinflammatory diseases.

The main product types of neuro immunoassay are reagents and kits, and analyzers. Reagents and kits refer to standardized assay components used to detect and quantify neurological biomarkers in biological samples, enabling the diagnosis, monitoring, and research of neurological disorders. The technologies such as radioimmunoassays, polymerase chain reaction, enzyme-linked immunosorbent assay, western blot, rapid tests, and enzyme-linked immunospot assay. The analyte or biomarker type amyloid-beta, tau protein, alpha-synuclein, neurofilament light chain, autoantibodies, cytokines, glial fibrillary acidic protein, neuron-specific enolase, ubiquitin C-terminal hydrolase L1, and brain-derived neurotrophic factor. The applications such as alzheimer’s disease, parkinson’s disease, huntington’s disease, amyotrophic lateral sclerosis, and spinal muscular atrophy, and the key end users including hospitals, clinics, academic organizations, biopharmaceutical companies, pharmaceutical companies, and others.

Neuro Immunoassay market report bar graph

What Is The Neuro Immunoassay Market Size and Share 2026?

The neuro immunoassay (NIA) market size has grown strongly in recent years. It will grow from $2.88 billion in 2025 to $3.12 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growing demand for sensitive neurological diagnostics, increasing adoption of immunoassay techniques in neuroscience research, rising prevalence of neurodegenerative disorders, expansion of clinical and research laboratories, and growing focus on early disease detection and monitoring.

What Is The Neuro Immunoassay Market Growth Forecast?

The neuro immunoassay (NIA) market size is expected to see strong growth in the next few years. It will grow to $4.28 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing integration of neuro immunoassay (NIA) with artificial intelligence (AI) data analysis, rising investment in biomarker discovery, growing adoption of personalized medicine and therapeutic monitoring, expansion of high-throughput screening platforms, and a rise in demand for automated and precise immunoassay systems. Major trends in the forecast period include technology-driven innovations in assay sensitivity and specificity, advancements in artificial intelligence (AI)-enabled data interpretation, developments in multiplexed and lab-on-a-chip immunoassay systems, rising research and development in neuro biomarker identification, and innovation in integrated and automated neurodiagnostic platforms.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Neuro Immunoassay Market Segmentation

1) By Product Type: Reagents And Kits, Analyzers

2) By Technology: Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests, Enzyme-Linked Immunospot Assay (ELISPOT)

3) By Analyte Or Biomarker Type: Amyloid-Beta (Aß), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1), Brain-Derived Neurotrophic Factor (BDNF)

4) By Application: Alzheimer’s Disease, Parkinson’s Disease (PD), Huntington’s Disease, Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA)

5) By End-User: Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Reagents And Kits: Enzyme Linked Immunosorbent Assay Reagents, Western Blotting Kits, Multiplex Assay Kits

2) By Analyzers: Automated Immunoassay Analysers, Point Of Care Immunoassay Analysers, High Throughput Immunoassay Analysers

What Is The Driver Of The Neuro Immunoassay Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the neuro immunoassay market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, disrupting normal nervous system function and leading to impairments in movement, cognition, sensation, behavior, or overall bodily control. The increasing prevalence of neurological disorders is due to unhealthy lifestyle habits, including poor diet, physical inactivity, smoking, excessive alcohol consumption, and chronic stress. Neuro immunoassays help detect specific biomarkers in the nervous system, supporting early diagnosis and targeted treatment for neurological patients. For instance, in April 2024, according to the National Institutes of Health (NIH), a US-based government agency, an estimated 6.9 million Americans aged 65 and older are currently living with Alzheimer’s dementia, and this figure is projected to nearly double to 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders drives the neuro immunoassay industry.

Key Players In The Global Neuro Immunoassay Market

Major companies operating in the neuro immunoassay market are Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Meso Scale Diagnostics LLC, Sino Biological Inc., Quanterix Corporation, Cusabio Technology LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., RayBiotech Life Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Assay Genie Ltd., Novus Biologicals LLC, Creative Diagnostics, MyBioSource Inc., Immuno-Biological Laboratories Co. Ltd., Boster Biological Technology, Cloud-Clone Corp., FineTest Biotech Inc., Abbexa Ltd.

Global Neuro Immunoassay Market Trends and Insights

Major companies operating in the neuro immunoassay market are focusing on developing advanced solutions, such as blood-based neurological biomarker assays, to enhance disease monitoring, improve prognostic accuracy, and support clinical decision-making in neurological disorders. Blood-based neurological biomarker assays refer to tests that measure specific proteins, such as Neurofilament Light Chain (NfL), in human serum or plasma to assess neuronal injury and disease activity. For instance, in June 2024, Siemens Healthineers, a Germany-based in vitro diagnostics company, achieved CE marking for its Neurofilament Light Chain blood test designed for use on the Atellica IM Analyzer and ADVIA Centaur systems. The test quantifies NfL levels to aid prediction of neuronal injury risk in adults with relapsing multiple sclerosis, complementing clinical, imaging, and laboratory assessments, and the CE mark reflects compliance with European In Vitro Diagnostic Regulations, expanding access to standardized neuro immunoassay diagnostics across European laboratories.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Neuro Immunoassay Market?

In May 2025, Sanofi, a France-based biopharmaceutical company specializing in immunology, vaccines, and neuroscience research, acquired Vigil Neuroscience Inc. for approximately $470 million. Through this acquisition, Sanofi aims to reinforce its early-stage neurology and neuroimmunology research capabilities by integrating Vigil’s oral TREM2 agonist VG 3927, a candidate targeting microglial immune pathways relevant in Alzheimer’s disease, into its development pipeline. Vigil Neuroscience Inc. is a US-based clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative diseases such as Alzheimer’s disease, with programs centered on immune-modulating mechanisms in the central nervous system.

Regional Insights

North America was the largest region in the neuro immunoassay (NIA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neuro Immunoassay Market?

The neuro immunoassay market consists of revenues earned by entities by providing services such as enzyme-linked immunosorbent assay (ELISA) kits, multiplex immunoassay platforms, chemiluminescent immunoassays, electrochemiluminescent immunoassays, and high-throughput assay systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuro immunoassay (NIA) includes sales of assay reagents, detection instruments, sample preparation kits, and automated immunoassay analyzers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neuro Immunoassay Market Report 2026?

The neuro immunoassay market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neuro immunoassay industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neuro Immunoassay Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.12 billion
Revenue Forecast In 2035 $4.28 billion
Growth Rate CAGR of 8.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Technology, Analyte Or Biomarker Type, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Meso Scale Diagnostics LLC, Sino Biological Inc., Quanterix Corporation, Cusabio Technology LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., RayBiotech Life Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Assay Genie Ltd., Novus Biologicals LLC, Creative Diagnostics, MyBioSource Inc., Immuno-Biological Laboratories Co. Ltd., Boster Biological Technology, Cloud-Clone Corp., FineTest Biotech Inc., Abbexa Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neuro Immunoassay Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neuro Immunoassay Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neuro Immunoassay Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neuro Immunoassay Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Multiplex Neuro Biomarker Assays

4.2.2 Rising Use Of Automated Immunoassay Analyzers

4.2.3 Growing Demand For Early Neurodegenerative Diagnostics

4.2.4 Expansion Of Personalized Neurology Testing

4.2.5 Enhanced Focus On High-Sensitivity Assay Platforms

5. Neuro Immunoassay Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Academic Organizations

5.4 Biopharmaceutical Companies

5.5 Pharmaceutical Companies

6. Neuro Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuro Immunoassay Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neuro Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neuro Immunoassay Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neuro Immunoassay Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neuro Immunoassay Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuro Immunoassay Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuro Immunoassay Market Segmentation

9.1. Global Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reagents And Kits, Analyzers

9.2. Global Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests, Enzyme-Linked Immunospot Assay (ELISPOT)

9.3. Global Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Amyloid-Beta (Aß), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1), Brain-Derived Neurotrophic Factor (BDNF)

9.4. Global Neuro Immunoassay Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alzheimer’s Disease, Parkinson’s Disease (PD), Huntington’s Disease, Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA)

9.5. Global Neuro Immunoassay Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies, Other End-Users

9.6. Global Neuro Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Enzyme Linked Immunosorbent Assay Reagents, Western Blotting Kits, Multiplex Assay Kits

9.7. Global Neuro Immunoassay Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Automated Immunoassay Analysers, Point Of Care Immunoassay Analysers, High Throughput Immunoassay Analysers

10. Neuro Immunoassay Market Regional And Country Analysis

10.1. Global Neuro Immunoassay Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neuro Immunoassay Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuro Immunoassay Market

11.1. Asia-Pacific Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuro Immunoassay Market

12.1. China Neuro Immunoassay Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuro Immunoassay Market

13.1. India Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuro Immunoassay Market

14.1. Japan Neuro Immunoassay Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuro Immunoassay Market

15.1. Australia Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuro Immunoassay Market

16.1. Indonesia Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuro Immunoassay Market

17.1. South Korea Neuro Immunoassay Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuro Immunoassay Market

18.1. Taiwan Neuro Immunoassay Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuro Immunoassay Market

19.1. South East Asia Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuro Immunoassay Market

20.1. Western Europe Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuro Immunoassay Market

21.1. UK Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuro Immunoassay Market

22.1. Germany Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuro Immunoassay Market

23.1. France Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuro Immunoassay Market

24.1. Italy Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuro Immunoassay Market

25.1. Spain Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuro Immunoassay Market

26.1. Eastern Europe Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuro Immunoassay Market

27.1. Russia Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuro Immunoassay Market

28.1. North America Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuro Immunoassay Market

29.1. USA Neuro Immunoassay Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuro Immunoassay Market

30.1. Canada Neuro Immunoassay Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuro Immunoassay Market

31.1. South America Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuro Immunoassay Market

32.1. Brazil Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuro Immunoassay Market

33.1. Middle East Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuro Immunoassay Market

34.1. Africa Neuro Immunoassay Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Neuro Immunoassay Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuro Immunoassay Market Regulatory and Investment Landscape

36. Neuro Immunoassay Market Competitive Landscape And Company Profiles

36.1. Neuro Immunoassay Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neuro Immunoassay Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neuro Immunoassay Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Abcam plc Overview, Products and Services, Strategy and Financial Analysis

37. Neuro Immunoassay Market Other Major And Innovative Companies

BioLegend Inc., Meso Scale Diagnostics LLC, Sino Biological Inc., Quanterix Corporation, Cusabio Technology LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., RayBiotech Life Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Assay Genie Ltd., Novus Biologicals LLC, Creative Diagnostics, MyBioSource Inc., Immuno-Biological Laboratories Co. Ltd.

38. Global Neuro Immunoassay Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuro Immunoassay Market

40. Neuro Immunoassay Market High Potential Countries, Segments and Strategies

40.1 Neuro Immunoassay Market In 2030 - Countries Offering Most New Opportunities

40.2 Neuro Immunoassay Market In 2030 - Segments Offering Most New Opportunities

40.3 Neuro Immunoassay Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Neuro Immunoassay Market, Overview Of Key Products - Product Examples
  • Table 2: Global Neuro Immunoassay Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Neuro Immunoassay Market, Supply Chain Analysis
  • Table 4: Global Neuro Immunoassay Market, Major Raw Material Providers
  • Table 5: Global Neuro Immunoassay Market, Major Resource Providers
  • Table 6: Global Neuro Immunoassay Market, Major Manufacturers (Suppliers)
  • Table 7: Global Neuro Immunoassay Market, Major Distributors And Channel Partners
  • Table 8: Global Neuro Immunoassay Market, Key Technologies & Future Trends
  • Table 9: Global Neuro Immunoassay Market, Major Trends
  • Table 10: Global Neuro Immunoassay Market, Major End Users
  • Table 11: Global Neuro Immunoassay Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Neuro Immunoassay Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Neuro Immunoassay Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Neuro Immunoassay Market - TAM, US$ Billion, 2025
  • Table 15: Global Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Neuro Immunoassay Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Neuro Immunoassay Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Neuro Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Neuro Immunoassay Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Neuro Immunoassay Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Neuro Immunoassay Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Neuro Immunoassay Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Neuro Immunoassay Market - Company Scoring Matrix
  • Table 98: Thermo Fisher Scientific Inc. Financial Performance
  • Table 99: Merck KGaA Financial Performance
  • Table 100: Bio-Rad Laboratories Inc. Financial Performance
  • Table 101: GenScript Biotech Corporation Financial Performance
  • Table 102: Abcam plc Financial Performance
  • Table 103: Global Neuro Immunoassay Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Neuro Immunoassay Market, Competitive Dashboard
  • Table 105: Global Neuro Immunoassay Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Neuro Immunoassay Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 107: Global, Neuro Immunoassay Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 108: Global, Neuro Immunoassay Market Size Gain ($ Billion), Segmentation By Analyte Or Biomarker Type, 2025 – 2030

List Of Figures

    Figure 1: Global Neuro Immunoassay Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Neuro Immunoassay Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Neuro Immunoassay Market, Supply Chain Analysis
  • Figure 4: Global Neuro Immunoassay Market, Major Raw Material Providers
  • Figure 5: Global Neuro Immunoassay Market, Major Resource Providers
  • Figure 6: Global Neuro Immunoassay Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Neuro Immunoassay Market, Major Distributors And Channel Partners
  • Figure 8: Global Neuro Immunoassay Market, Key Technologies & Future Trends
  • Figure 9: Global Neuro Immunoassay Market, Major Trends
  • Figure 10: Global Neuro Immunoassay Market, Major End Users
  • Figure 11: Global Neuro Immunoassay Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Neuro Immunoassay Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Neuro Immunoassay Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Neuro Immunoassay Market - TAM, US$ Billion, 2025
  • Figure 15: Global Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Neuro Immunoassay Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Neuro Immunoassay Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Neuro Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Neuro Immunoassay Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Neuro Immunoassay Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Neuro Immunoassay Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Neuro Immunoassay Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Neuro Immunoassay Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Neuro Immunoassay Market, Segmentation By Analyte Or Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Neuro Immunoassay Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Neuro Immunoassay Market - Company Scoring Matrix
  • Figure 98: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 99: Merck KGaA Financial Performance
  • Figure 100: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 101: GenScript Biotech Corporation Financial Performance
  • Figure 102: Abcam plc Financial Performance
  • Figure 103: Global Neuro Immunoassay Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Neuro Immunoassay Market, Competitive Dashboard
  • Figure 105: Global Neuro Immunoassay Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Neuro Immunoassay Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 107: Global, Neuro Immunoassay Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 108: Global, Neuro Immunoassay Market Size Gain ($ Billion), Segmentation By Analyte Or Biomarker Type, 2025 – 2030

2025 Analysis: Opportunities and Risks in the Evolving Healthcare Chromatography Analyzers Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Healthcare Chromatography Analyzers Market

Future Projections: Healthcare Smart Card Reader Market to Reach $3.12 Billion by 2029 at 17.8% CAGR

Read More About Future Projections: Healthcare Smart Card Reader Market to Reach $3.12 Billion by 2029 at 17.8% CAGR

Industry Forecast: Hemostatic Agents Market to Generate $5.43 Billion Revenue by 2029

Read More About Industry Forecast: Hemostatic Agents Market to Generate $5.43 Billion Revenue by 2029

CAGR of 6.6% Projected for Hemostats And Tissue Sealants Market From 2025 to 2029

Read More About CAGR of 6.6% Projected for Hemostats And Tissue Sealants Market From 2025 to 2029

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Immunoglobulins Market Report 2026 - Global Outlook – By Product (IGG, IGA, IGM, IGE, IGD), By Mode Of Delivery (Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery ), By Application (Hypogammaglobulinemia, Chron...

Immunomodulator Market Report 2026 - Global Outlook – By Product Type (Immunosuppressants, Immunostimulants, Other Product Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distr...

Neuroscience Antibodies & Assays Market Report 2026 - Global Outlook – By Product (Consumables, Instruments), By Technology (Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies), By Application (In...

Immunotoxin Market Report 2026 - Global Outlook – By Type (Anthrax Based Toxins, Diphtheria Toxin (DT) And Derivatives, Pseudomonas Exotoxin (PE) And Derivatives, Ribosome Inactivating Proteins Based Immunotoxins, Ribonu...

Immunodiagnostics Market Report 2026 - Global Outlook – By Product (Reagents And Consumables, Instruments), By Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid ...

Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

Frequently Asked Questions

The Neuro Immunoassay Market Report 2026 market was valued at $2.88 billion in 2025, increased to $3.12 billion in 2026, and is projected to reach $4.28 billion by 2030. request a sample here

The expected CAGR for the Neuro Immunoassay market during the forecast period 2025–2030 is 8.2%. request a sample here

Major growth driver of the market includes: Growing Burden Of Neurological Conditions Driving Market Demand Due To Rising Prevalence And Early Diagnosis Needs in the Neuro Immunoassay market. For further insights on this market, request a sample here

The neuro immunoassay market covered in this report is segmented –
1) By Product Type: Reagents And Kits, Analyzers
2) By Technology: Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests, Enzyme-Linked Immunospot Assay (ELISPOT)
3) By Analyte Or Biomarker Type: Amyloid-Beta (Aβ), Tau Protein (p-Tau), Alpha-Synuclein (α-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1), Brain-Derived Neurotrophic Factor (BDNF)
4) By Application: Alzheimer’s Disease, Parkinson’s Disease (PD), Huntington’s Disease, Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA)
5) By End-User: Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies, Other End-Users Subsegments:
1) By Reagents And Kits: Enzyme Linked Immunosorbent Assay Reagents, Western Blotting Kits, Multiplex Assay Kits
2) By Analyzers: Automated Immunoassay Analysers, Point Of Care Immunoassay Analysers, High Throughput Immunoassay Analysers request a sample here

Major trend in this market includes: Developing Blood-Based Neurological Biomarker Assays To Enhance Neuro Immunoassay Diagnostics And Disease Monitoring For further insights on this market, request a sample here.

Major companies operating in the Neuro Immunoassay market are Major companies operating in the neuro immunoassay market are Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Meso Scale Diagnostics LLC, Sino Biological Inc., Quanterix Corporation, Cusabio Technology LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., RayBiotech Life Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Assay Genie Ltd., Novus Biologicals LLC, Creative Diagnostics, MyBioSource Inc., Immuno-Biological Laboratories Co. Ltd., Boster Biological Technology, Cloud-Clone Corp., FineTest Biotech Inc., Abbexa Ltd. request a sample here.

North America was the largest region in the neuro immunoassay (NIA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuro immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us